20
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Machine Learning-Based Prediction of In-Stent Restenosis Risk Using Systemic Inflammation Aggregation Index Following Coronary Stent Placement

ORCID Icon, , , &
Pages 1779-1786 | Received 11 Mar 2024, Accepted 24 Jun 2024, Published online: 05 Jul 2024

References

  • Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169–177. doi:10.2991/jegh.k.201217.001
  • Hoole SP, Bambrough P. Recent advances in percutaneous coronary intervention. Heart. 2020;106(18):1380–1386. doi:10.1136/heartjnl-2019-315707
  • Giustino G, Colombo A, Camaj A, et al. Coronary In-Stent restenosis: JACC State-of-the-Art review. J Am Coll Cardiol. 2022;80(4):348–372. doi:10.1016/j.jacc.2022.05.017
  • Marfella R, Sardu C, D’Onofrio N, et al. SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes. BMC Med. 2023;21(1):71. doi:10.1186/s12916-023-02781-2
  • Yang X, Yang Y, Guo J, et al. Targeting the epigenome in in-stent restenosis: from mechanisms to therapy. Mol Ther Nucleic Acids. 2021;23:1136–1160. doi:10.1016/j.omtn.2021.01.024
  • Clare J, Ganly J, Bursill CA, Sumer H, Kingshott P, de Haan JB. The mechanisms of restenosis and relevance to next generation stent design. Biomolecules. 2022;12(3). doi:10.3390/biom12030430
  • Manjunatha K, Behr M, Vogt F, Reese S. A multiphysics modeling approach for in-stent restenosis: theoretical aspects and finite element implementation. Comput Biol Med. 2022;150:106166. doi:10.1016/j.compbiomed.2022.106166
  • Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897–1907. doi:10.1016/j.jacc.2010.07.028
  • Drachman DE, Simon DI. Inflammation as a mechanism and therapeutic target for in-stent restenosis. Curr Atheroscler Rep. 2005;7(1):44–49. doi:10.1007/s11883-005-0074-5
  • Kleinedler JJ, Orchard EA, Foley JD, Rogers LK, Hebert VY, Dugas TR. A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting. Atherosclerosis. 2011;219(2):484–491. doi:10.1016/j.atherosclerosis.2011.09.021
  • Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–380. doi:10.1038/nrneph.2017.51
  • McFadyen JD, Kaplan ZS. Platelets are not just for clots. Transfus Med Rev. 2015;29(2):110–119. doi:10.1016/j.tmrv.2014.11.006
  • Chen Y, Yu J, Shi L, et al. Systemic inflammation markers associated with bone mineral density in perimenopausal and postmenopausal women. J Inflamm Res. 2023;16:297–309. doi:10.2147/jir.S385220
  • Xiu J, Lin X, Chen Q, et al. The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension. Front Cardiovasc Med. 2023;10:1163900. doi:10.3389/fcvm.2023.1163900
  • Yang Y, Xu Y, Liu S, Lu P, Zhou H, Yang M. The systemic inflammation indexes predict all-cause mortality in peritoneal dialysis patients. Ren Fail. 2023;45(1):2160348. doi:10.1080/0886022x.2022.2160348
  • Zinellu A, Paliogiannis P, Mangoni AA. Aggregate Index of Systemic Inflammation (AISI), disease severity, and mortality in COVID-19: a systematic review and meta-analysis. J Clin Med. 2023;12(14). doi:10.3390/jcm12144584
  • Zinellu A, Collu C, Nasser M, et al. The Aggregate Index of Systemic Inflammation (AISI): a novel prognostic biomarker in idiopathic pulmonary fibrosis. J Clin Med. 2021;10(18). doi:10.3390/jcm10184134
  • Nakamura D, Dohi T, Ishihara T, et al. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis. EuroIntervention. 2021;17(6):489–496. doi:10.4244/eij-d-20-00539
  • Tejada B, Joehanes R, Hwang SJ, et al. Systemic inflammation is associated with cardiometabolic risk factors and clinical outcomes. J Inflamm Res. 2022;15:6891–6903. doi:10.2147/jir.S382620
  • Paliogiannis P, Ginesu GC, Tanda C, et al. Inflammatory cell indexes as preoperative predictors of hospital stay in open elective thoracic surgery. ANZ J Surg. 2018;88(6):616–620. doi:10.1111/ans.14557
  • Wu B, Mottola G, Schaller M, Upchurch GR Jr, Conte MS. Resolution of vascular injury: specialized lipid mediators and their evolving therapeutic implications. Mol Aspects Med. 2017;58:72–82. doi:10.1016/j.mam.2017.07.005
  • Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–2434. doi:10.1161/circulationaha.106.658237
  • Kuznetsova T, Prange KHM, Glass CK, de Winther MPJ. Transcriptional and epigenetic regulation of macrophages in atherosclerosis. Nat Rev Cardiol. 2020;17(4):216–228. doi:10.1038/s41569-019-0265-3
  • van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166–179. doi:10.1038/s41569-018-0110-0
  • Jin Q, Fu L, Yang H, et al. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis. J Intern Med. 2023;293(4):494–507. doi:10.1111/joim.13607
  • Denorme F, Campbell RA. Procoagulant platelets: novel players in thromboinflammation. Am J Physiol Cell Physiol. 2022;323(4):C951–C958. doi:10.1152/ajpcell.00252.2022
  • Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J. 2021;42(28):2745–2760. doi:10.1093/eurheartj/ehab221
  • Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost. 2011;106(5):827–838. doi:10.1160/th11-08-0592